Your browser doesn't support javascript.
loading
Clinical Trial Protocol for PRIMARY2: A Multicentre, Phase 3, Randomised Controlled Trial Investigating the Additive Diagnostic Value of [68Ga]Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Negative or Equivocal Multiparametric Magnetic Resonance Imaging for the Diagnosis of Clinically Significant Prostate Cancer.
Buteau, James P; Moon, Daniel; Fahey, Michael T; Roberts, Matthew J; Thompson, James; Murphy, Declan G; Papa, Nathan; Mitchell, Catherine; De Abreu Lourenco, Richard; Dhillon, Haryana M; Kasivisvanathan, Veeru; Francis, Roslyn J; Stricker, Phillip; Agrawal, Shihka; O'Brien, Jonathan; McVey, Aoife; Sharma, Gaurav; Levy, Sidney; Ayati, Narjess; Nguyen, Andrew; Lee, Su-Faye; Pattison, David A; Sivaratnam, Dinesh; Frydenberg, Mark; Du, Yang; Titus, Jehan; Lee, Sze-Ting; Ischia, Joseph; Jack, Greg; Hofman, Michael S; Emmett, Louise.
Afiliação
  • Buteau JP; Prostate Cancer Theranostics and Imaging Centre of Excellence, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia. Electronic address: jamespatrick.buteau@unimelb.edu.au.
  • Moon D; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Royal Melbourne Clinical School, University of Melbourne, Melbourne, Australia.
  • Fahey MT; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; Centre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Roberts MJ; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Australia; UQ Centre for Clinical Research, Faculty of Medicine, University of Queensland, Brisbane, Australia.
  • Thompson J; Department of Urology, St. George Hospital, Sydney, Australia.
  • Murphy DG; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Papa N; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
  • Mitchell C; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • De Abreu Lourenco R; Centre for Health Economics Research and Evaluation, University of Technology Sydney, Sydney, Australia.
  • Dhillon HM; Psycho-Oncology Cooperative Research Group, Centre for Medical Psychology & Evidence-based Decision-making, University of Sydney, Camperdown, Australia.
  • Kasivisvanathan V; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Division of Surgery and Interventional Science, University College London, London, UK.
  • Francis RJ; Department of Nuclear Medicine, Sir Charles Gairdner Hospital, Perth, WA, Australia; Medical School, University of Western Australia, Perth, Australia.
  • Stricker P; St. Vincent's Prostate Cancer Research Centre, Garvan Institute, UNSW Sydney, Sydney, Australia; Department of Urology, St. Vincent's Hospital, Sydney, Australia.
  • Agrawal S; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, Australia; Faculty of Medicine, UNSW Sydney, Sydney, Australia.
  • O'Brien J; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • McVey A; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Sharma G; Prostate Cancer Theranostics and Imaging Centre of Excellence, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Levy S; Prostate Cancer Theranostics and Imaging Centre of Excellence, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; Department of Nuclear Medicine, Royal Melbourne Hospital, Melbourne, Australia; Department of
  • Ayati N; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, Australia; Faculty of Medicine, UNSW Sydney, Sydney, Australia.
  • Nguyen A; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, Australia; Faculty of Medicine, UNSW Sydney, Sydney, Australia.
  • Lee SF; Prostate Cancer Theranostics and Imaging Centre of Excellence, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Pattison DA; Department of Nuclear Medicine and Specialised PET Services, Royal Brisbane and Women's Hospital, Brisbane, Australia; School of Medicine, University of Queensland, Brisbane, Australia.
  • Sivaratnam D; Department of Nuclear Medicine, Royal Melbourne Hospital, Melbourne, Australia; Department of Nuclear Medicine, Cabrini Health, Melbourne, Australia.
  • Frydenberg M; Department of Surgery, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia; Cabrini Research, Cabrini Health, Melbourne, Australia.
  • Du Y; Department of Nuclear Medicine, PET and Bone Densitometry, South Australia Medical Imaging, Royal Adelaide Hospital, Adelaide, Australia.
  • Titus J; Department of Urology, Royal Adelaide Hospital, Adelaide, Australia.
  • Lee ST; Department of Medicine, University of Melbourne, Melbourne, Australia; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Australia.
  • Ischia J; University of Melbourne Department of Surgery, Austin Health, Melbourne, Australia.
  • Jack G; University of Melbourne Department of Surgery, Austin Health, Melbourne, Australia.
  • Hofman MS; Prostate Cancer Theranostics and Imaging Centre of Excellence, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.
  • Emmett L; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, Australia; Faculty of Medicine, UNSW Sydney, Sydney, Australia.
Eur Urol Oncol ; 2023 Dec 06.
Article em En | MEDLINE | ID: mdl-38061976
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Eur Urol Oncol Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Eur Urol Oncol Ano de publicação: 2023 Tipo de documento: Article